Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation].
Khat'kova SE, Baikova A, Maisonobe P, Khasanova DR. Khat'kova SE, et al. Among authors: maisonobe p. Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(11):39-48. doi: 10.17116/jnevro202112111139. Zh Nevrol Psikhiatr Im S S Korsakova. 2021. PMID: 34932284 Russian.
Results from the Upper Limb International Spasticity Study-II (ULISII):a large, international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin A in real-life clinical management.
Turner-Stokes L, Fheodoroff K, Jacinto J, Maisonobe P. Turner-Stokes L, et al. Among authors: maisonobe p. BMJ Open. 2013 Jun 20;3(6):e002771. doi: 10.1136/bmjopen-2013-002771. BMJ Open. 2013. PMID: 23794582 Free PMC article.
Factors influencing goal attainment in patients with post-stroke upper limb spasticity following treatment with botulinum toxin A in real-life clinical practice: sub-analyses from the Upper Limb International Spasticity (ULIS)-II Study.
Fheodoroff K, Ashford S, Jacinto J, Maisonobe P, Balcaitiene J, Turner-Stokes L. Fheodoroff K, et al. Among authors: maisonobe p. Toxins (Basel). 2015 Apr 8;7(4):1192-205. doi: 10.3390/toxins7041192. Toxins (Basel). 2015. PMID: 25856546 Free PMC article.
Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III).
Turner-Stokes L, Ashford S, Jacinto J, Maisonobe P, Balcaitiene J, Fheodoroff K. Turner-Stokes L, et al. Among authors: maisonobe p. BMJ Open. 2016 Jun 17;6(6):e011157. doi: 10.1136/bmjopen-2016-011157. BMJ Open. 2016. PMID: 27315835 Free PMC article.
Effectiveness of botulinum neurotoxin type A injections in naïve and previously-treated patients suffering from Torti- or Laterocollis or -caput: Results from a German-Austrian open-label prospective post-marketing surveillance study.
Jost WH, Schramm A, Müngersdorf M, Stenner A, Schwingenschuh P, Maisonobe P, Koch M, Haslinger B. Jost WH, et al. Among authors: maisonobe p. J Neurol Sci. 2019 Apr 15;399:44-50. doi: 10.1016/j.jns.2019.02.017. Epub 2019 Feb 10. J Neurol Sci. 2019. PMID: 30771702 Free article.
Botulinum toxin treatment of spasticity targeted to muscle endplates: an international, randomised, evaluator-blinded study comparing two different botulinum toxin injection strategies for the treatment of upper limb spasticity.
Rekand T, Biering-Sörensen B, He J, Vilholm OJ, Christensen PB, Ulfarsson T, Belusa R, Ström T, Myrenfors P, Maisonobe P, Dalager T. Rekand T, et al. Among authors: maisonobe p. BMJ Open. 2019 May 5;9(5):e024340. doi: 10.1136/bmjopen-2018-024340. BMJ Open. 2019. PMID: 31061021 Free PMC article. Clinical Trial.
74 results